TY  - JOUR
AU  - Falco, Agustín
AU  - de Oliveira, Thiago Bueno
AU  - Cacicedo, Jon
AU  - Ospina, Aylen Vanessa
AU  - Ticona, Miguel Ángel
AU  - Galindo, Héctor
AU  - Pereira, Marcos David
AU  - Aguilar-Ponce, José Luis
AU  - Rueda-Domínguez, Antonio
AU  - Soria, Tannia
AU  - Taberna, Miren
AU  - Iglesias, Lara
AU  - Sowley, Taysser
AU  - Mesía, Ricard
AU  - TTCC group (Spanish Group for the Treatment of the Head and Neck Cancer)
PY  - 2021
DO  - 10.2147/CMAR.S322411
SN  - 1179-1322
UR  - https://hdl.handle.net/10668/26712
T2  - Cancer management and research
AB  - Cisplatin is the standard of treatment for squamous cell carcinoma of the head and neck (SCCHN) that has demonstrated efficacy, either in locally advanced disease when combined with radiotherapy at high doses, or in metastatic/recurrent disease when...
LA  - en
KW  - age
KW  - cisplatin
KW  - comorbidities
KW  - contraindication
KW  - frailty
KW  - toxicity
TI  - Ibero-American Expert Consensus on Squamous Cell Carcinoma of the Head and Neck Treatment in Patients Unable to Receive Cisplatin: Recommendations for Clinical Practice.
TY  - research article
VL  - 13
ER  -